Article
Alvotech Begins Confirmatory Study On EYLEA® Biosimilar
Last week Alvotech announced that it has initiated a confirmatory study for its biosimilar candidate to EYLEA®, AVT06 (aflibercept). EYLEA® is indicated for treating a variety of eye disorders...
Goodwin Procter LLP






